drugset / Trial / NCT05580445
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the safety, tolerability, pharmacokinetics and antineoplastic activity of CT-707 in combination with toripalimab and gemcitabine in patients with advanced pancreatic cancer
Timeline
- Start
- 2022-08-11
- Primary completion
- 2024-08-11
- Completion
- 2024-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Conteltinib | Small molecule | — | — |
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Toripalimab | Monoclonal antibody | — | — |